| rivaroxaban / Generic mfg. |
REVNEWANTICO, NCT01210755: Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thrombotics |
|
|
| Completed | 4 | 10 | Europe | Rivaroxaban, Dabigatran, Xarelto, Pradaxa, Dabigatran; Rivaroxaban | University Hospital, Grenoble | Venous Thromboembolism | 03/11 | 06/11 | | |
NCT02379663: Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty |
|
|
| Completed | 4 | 639 | RoW | Rivaroxaban, Enoxaparin, Normal saline | Samsung Medical Center | Osteoarthritis, Hip, Femur Head Necrosis, Femoral Neck Fractures | 01/13 | 01/13 | | |
ChiCTR-TRC-14005223: Efficacy and Safety of rivaroxaban or warfarin on venous thromboembolic disease: A Randomized controlled trial |
|
|
| Recruiting | 4 | 40 | | Warfarin ;rivaroxaban | State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Diseases, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China; First Affiliated Hospital of Guangzhou Medical Uni, self-financing | venous thromboembolic disease | | | | |
NCT02054936: Evaluation of Wound Drainage After Knee or Hip Arthroplasty |
|
|
| Withdrawn | 4 | 0 | US | Rivaroxaban (Xarelto), Warfarin (Coumadin) | University of Michigan | Complications; Arthroplasty | 02/16 | 02/16 | | |
NCT01708850: Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2) |
|
|
| Completed | 4 | 70 | Canada | Rivaroxaban, Xarelto | London Health Sciences Centre | Neoplasm, Central Venous Catheter Thrombosis | 05/16 | 06/16 | | |
NCT02453802: Comparison of Topical and Infusion Tranexamic Acid After Total Knee Arthroplasty |
|
|
| Unknown status | 4 | 90 | RoW | Tranexamic Acid 5%,5ml/amp, Transamine, rivaroxaban (10mg), Xarelto, 0.9% Normal Saline, 0.9% sodium chloride | Chang Gung Memorial Hospital | Osteoarthritis, Knee | 05/16 | 05/16 | | |
| Terminated | 4 | 10 | NA | rivaroxaban, Xarelto, warfarin, Coumadin | Susan Smyth, Janssen Scientific Affairs, LLC | Pulmonary Embolism, Venous Thrombosis | 06/16 | 06/16 | | |
NCT01989845: Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer |
|
|
| Completed | 4 | 127 | RoW | Rivaroxaban, Xarelto | Seoul National University Hospital, Korean Society of Hematology Thrombosis Working Party | Rivaroxaban, Cancer-associated Thrombosis, Recurrence, Bleeding | 12/16 | 12/16 | | |
| Completed | 4 | 51 | Europe | Rivaroxaban, Xarelto, Fluindione, Previscan, Warfarin | University Hospital, Angers | Permanent Atrial Fibrillation, Venous Thrombosis, Pulmonary Embolism, Anticoagulation Treatment at Least > or = to 12-month | 12/16 | 02/18 | | |
ChiCTR-IPR-17012975: Effect of rivaroxaban on venous thromboembolism after posterior lumbar interbody fusion in elderly patients |
|
|
| Completed | 4 | 120 | | Rivaroxaban ;placebo | Guangzhou Panyu Hospital of Chinese Medicine; Guangzhou Panyu Hospital of Chinese Medicine, none | Venous thromboembolism | | | | |
| Completed | 4 | 81 | Canada | Rivaroxaban, Xarelto | St. Joseph's Healthcare Hamilton, Heart and Stroke Foundation of Canada, Bayer, Hamilton Health Sciences Corporation, Jewish General Hospital, University of Alberta, The Ottawa Hospital, Queen Elizabeth II Health Sciences Centre | Antiphospholipid Antibody Syndrome | 09/17 | 09/17 | | |
| Completed | 4 | 72 | Canada | Apixaban, Eliquis, Rivaroxaban, Xarelto | Ottawa Hospital Research Institute, Canadian Institutes of Health Research (CIHR), Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network | Venous Thromboembolism | 11/17 | 02/18 | | |
ChiCTR-OPC-17011716: Analysis of the association among rivaroxaban blood concentration, anti-factor Xa activity and clinical prognosis in patients with deep vein thrombosis (DVT) treated with rivaroxaban |
|
|
| Recruiting | 4 | 70 | | rivaroxaban | Peking Union Medical College Hospital; Peking Union Medical College Hospital, self-raised fund | Deep vein thrombosis | | | | |
2018-001443-31: DOAC concentrations in blood prior to surgery study: DALI study |
|
|
| Not yet recruiting | 4 | 300 | Europe | Dabigatran, Rivaroxaban, Apixaban, EU/1/08/442/001, EU/1/08/472/025, EU/1/11/691/015, Capsule, hard, Coated tablet, Pradaxa, Xarelto, Eliquis | Leiden University Medical Center, Leiden University Medical Center | No medical condition will be investigated. This study will only investigate DOAC levels during surgery. Patients who use DOACs are patients with venous thrombosis and atrial fibrillation., No medical condition will be investigated. This study will only investigate DOAC levels during surgery. Patients who use DOACs are patients with venous thrombosis and atrial fibrillation., Not possible to specify | | | | |
ChiCTR1800016829: anti-coagulation effect of aspirin, LMWH and rivaroxaban after total hip arthroplasty:a prospective randomised control trial |
|
|
| Recruiting | 4 | 240 | | aspirin ;LMWH ;rivaroxaban | Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University; Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University, self-fund | arthroplasty | | | | |
ChiCTR-OPC-17012858: Safety and effectiveness of rivaroxaban in anticoagulation therapy for elderly patients with atrial fibrillation and venous thromboembolism: a prospective observational study |
|
|
| Recruiting | 4 | 200 | | rivaroxaban ;non-rivaroxaban | Xinhua Hospital Affiliated to Shanghai JiaoTong University School of Medicine; Xinhua Hospital Affiliated to Shanghai JiaoTong University School of Medicine, Self-financing | thrombosis | | | | |
ChiCTR1800016430: Combined use of rivaroxaban and tranexamic acid for hemorrhage and thrombosis management in spine surgery |
|
|
| Recruiting | 4 | 2000 | | nothing ;Preoperative and intraoperative application of tranexamic acid ;Oral rivaroxaban 8 h after surgery, applied 35 days after surgery ;Preoperative and intraoperative application of tranexamic acid,oral rivaroxaban 8 h after surgery, applied 35 days after surgery | Qilu Hospital of Shandong University; Qilu Hospital of Shandong University, Self-fund | Venous thromboembolism | | | | |
| Terminated | 4 | 44 | US | Warfarin, Apixaban 2.5 MG, Rivaroxaban 10 MG | Duke University, Patient-Centered Outcomes Research Institute | Venous Thromboembolism | 05/19 | 05/19 | | |
| Completed | 4 | 90 | RoW | Rivaroxaban, xarelto, Diosmin, flebodia, compression stockings | Pirogov Russian National Research Medical University | Deep Vein Thrombosis, Postthrombotic Syndrome | 07/19 | 07/19 | | |
ChiCTR1800018927: Combined application of rivaroxaban and tranexamic acid in the management of hemorrhage and thrombosis in traumatic surgery |
|
|
| Not yet recruiting | 4 | 1200 | | Physical prophylaxis Lower limb thrombosis ;1g of intravenous tranexamic acid before incision, maintained at 15mg/kg during operation ;1g of tranexamic acid before incision, maintained at 15mg/kg during operation, and rivaroxaban 8 hours after operation | Qilu Hospital of Shandong University; Qilu Hospital of Shandong University, Self-fund | Venous thromboembolism | | | | |
ChiCTR1800020289: A randomized controlled trial for Aspirin or Rivaroxaban for venous thromboembolism prophylaxis after total joint arthroplasty |
|
|
| Recruiting | 4 | 120 | | aspirin 100mg bid after operation ;Rivaroxaban 10mg qd after operation | Peking Union Medical College Hospital; Peking Union Medical College Hospital, Orthopaedic department, Peking Union Medical College Hospital | osteoarthritis | | | | |
2014-005162-29: Treatment of thrombosis in the abdominal veins Behandeling van trombose in de buikvenen |
|
|
| Not yet recruiting | 4 | 100 | Europe | rivaroxaban, Tablet, rivaroxaban 20 mg | University of Insubria, Amsterdam UMC, location AMC | Splanchnic vein thrombosis (SVT) is an unusual site manifestation of venous thromboembolism (VTE). It includes the Budd-Chiari syndrome (BCS), portal vein thrombosis (PVT), mesenteric vein thrombosis (MVT) and splenic vein thrombosis (spVT). PVT is the most frequent manifestation of SVT, followed by MVT. Splanchische veneuze trombose (SVT) is wat locatie betreft een ongewoonlijke manifestatie van veneuze trombo-embolie (VTE). Het bevat de Budd-Chiari syndrome, vena porta trombose, vena mesenterica trombose en vena lienalis/splenica trombose., The condition called splanchnic vein thrombosis (SVT) which causes decreased blood flow through one of your splanchnic veins (portal, mesenteric, or splenic vein). d. Bij splanchnische veneuze trombose wordt obstructie veroorzaakt in 1 van de aderen van het maagdarmstelsel, hierdoor kan het zuurstofarme bloed niet meer goed verder kan stromen., Diseases [C] - Cardiovascular Diseases [C14] | | | | |
2018-003852-19: An Open Label, Non-Randomised, Phase IV Clinical Trial to Determine the Transfer of Apixaban and Rivaroxaban in Breast Milk Following Oral Administration |
|
|
| Not yet recruiting | 4 | 4 | Europe | Rivaroxaban, Apixaban, Film-coated tablet, Xarelto, Eliquis | King's College London, King's College Hospital NHS Foundation Trust, King's College London, Kings College London | healthy volunteers (Venous Thromboembolism), healthy volunteers (Blood clots during breast feeding), Diseases [C] - Blood and lymphatic diseases [C15] | | | | |
ChiCTR1900024985: Combined use of rivaroxaban and tranexamic acid for hemorrhage and thrombosis management in spine surgery |
|
|
| Not yet recruiting | 4 | 900 | | nothing ;The tranexamic acid 2g was intravenously instilled 30 minutes before the incision, and intraoperative local application of 1 g of tranexamic acid. ;Preoperative and intraoperative application of tranexamic acid,oral rivaroxaban 8 h after surgery, applied 35 days after surgery | Qilu Hospital of Shandong University; Qilu Hospital of Shandong University, self-funded | Venous thromboembolism | | | | |
NCT04169269: Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban |
|
|
| Unknown status | 4 | 128 | US | Enoxaparin 40 milligram/0.4 milliliter Injectable Syringe 0.4 milliliters, Lovenox, Rivaroxaban 10 milligram Oral Tablet, Xarelto | Florida Orthopaedic Institute, Orthopaedic Trauma Association | Deep Vein Thrombosis, Venous Thromboembolism | 12/20 | 12/21 | | |
ChiCTR1800019890: Effect of gene polymorphism on the efficacy of direct oral anticoagulant therapy in patients with venous thromboembolism |
|
|
| Not yet recruiting | 4 | 200 | | Dabigatran ;Rivaroxaban | Shanghai Pulmonary Hospital; Shanghai Pulmonary Hospital, shanghai pulmonary hospital | venous thromboembolism | | | | |
NCT04256525: Prophylactic Anticoagulation for Catheter-related Thrombosis |
|
|
| Unknown status | 4 | 1640 | RoW | Rivaroxaban 10mg, Aspirin 100mg, low molecule heparin | Second Affiliated Hospital, School of Medicine, Zhejiang University | Venous Thrombosis Due to Central Venous Access Device (Disorder), Prophylactic Anticoagulation, Patients With Tumor | 08/21 | 02/22 | | |
ChiCTR2000029081: Prospective Randomized Trial on Efficacy of Rivaroxaban and Wafarin on Preventing Vein Thromboembolism in Nephrotic Syndrome |
|
|
| Not yet recruiting | 4 | 144 | | 10mg/d Rivaroxaban on preventing vein thromboembolism ;Warfarin targeting INR 2-3 on preventing vein thromboembolism | Peking Union Medical College Hospital, Chinese Academy of Medical Science; Peking Union Medical College Hospital, Chinese Academy of Medical Science, Self-supporting | Nephrotic Syndrome | | | | |
ChiCTR2100042259: Effectiveness and safety of sulfonate in the prevention of venous thromboembolism after hip fracture |
|
|
| Recruiting | 4 | 90 | | Sulfonda liver decanodium 2.5mg, subcutaneous injection. ;Enoxaparin sodium 4000IU (Sanofi) subcutaneous injection ;Oral rivaroxaban 10mg (Bayer) | Affiliated Hospital of North Sichuan Medical College; Affiliated Hospital of North Sichuan Medical College, Sichuan Medical Association | Hip fracture | | | | |
ChiCTR2100049891: Sequential use of different anticoagulant drugs for prevention of venous thromboembolism in hospitalized patients with traumatic fractures: a multi-center, prospective and practical clinical study |
|
|
| Not yet recruiting | 4 | 7414 | | Fondaparinux (during hospitalization) + Rivaroxaban/low molecular weight heparin/Fondaparinux (after discharge); low molecular weight heparin (during hospitalization) + rivaroxaban/low molecular weight heparin/fondaparinux (after discharge) | Qilu Hospital of Shandong University; Qilu Hospital of Shandong University, China Red Cross Foundation | Prevention of venous thromboembolic events | | | | |
ChiCTR2100041689: Study on the correlation between the risk of thrombosis and bleeding after hip and knee replacement and the effect of anticoagulation |
|
|
| Recruiting | 4 | 600 | | aspirin ;Enoxaparin ;Rivaroxaban | The Second Affiliated Hospital of Kunming Medical University; The Second Affiliated Hospital of Kunming Medical University, The Second Affiliated Hospital of Kunming Medical University | Hip and knee replacement, deep vein thrombosis | | | | |
Ésquilo, NCT05303818: Chemoprophylaxis With Rivaroxaban for Lower Limb Deep Vein Thrombosis in Colorectal Cancer |
|
|
| Not yet recruiting | 4 | 68 | RoW | Rivaroxaban 10 MG | Hospital do Servidor Publico Estadual | Deep Venous Thrombosis, Colonic Cancer | 06/23 | 06/24 | | |
ChiCTR2200063471: Effect of Low-dose vs Standard-dose Rivaroxaban Prophylaxis on Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: a Randomized Clinical Trial |
|
|
| Not yet recruiting | 4 | 108 | | Rivaroxaban (5 mg po qd) ;Rivaroxaban (10 mg po qd) | The Second Affiliated Hospital of Chongqing Medical University; The Second Affiliated Hospital of Chongqing Medical University, Self-funded | Osteoarthritis | | | | |
ESRETP, ChiCTR2000036790: The efficacy and safety of Rivaroxaban and Enoxaparin for thromboprophylaxis after pulmonary surgery for cancer: a single, randomized, single-blind, parallel control clinical study. |
|
|
| Not yet recruiting | 4 | 740 | | oral take rivaroxaban ;Hypodermic injection of Enoxaparin | Shanghai Pulmonary Hospital; Shanghai Pulmonary Hospital, Shenkang Hospital Development Center of Shanghai | Venous Thromboembolism | | | | |
SAFE-SSPE, NCT04263038: Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism |
|
|
| Recruiting | 4 | 276 | Europe, Canada | Rivaroxaban, Placebo | Drahomir Aujesky, University of Bern, Schweizerischer Nationalfonds, Leiden University Medical Center, The Ottawa Hospital, Bayer | Pulmonary Embolism, Embolism, Embolism and Thrombosis, Lung Diseases, Cardiovascular Diseases, Respiratory Tract Diseases, Venous Thromboembolism, Anticoagulant-induced Bleeding, Bleeding | 05/26 | 05/26 | | |
| Terminated | 4 | 9 | Canada | tinzaparin, Rivaroxaban | Sunnybrook Health Sciences Centre, LEO Pharma, Sunnybrook Research Institute | Deep Vein Thrombosis, Post Thrombotic Syndrome | 01/24 | 01/24 | | |
COBRRA, NCT03266783: Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism |
|
|
| Recruiting | 4 | 2760 | Europe, Canada, RoW | Apixaban, Eliquis, Rivaroxaban, Xarelto | Ottawa Hospital Research Institute, Canadian Institutes of Health Research (CIHR), Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network | Venous Thromboembolism | 08/24 | 12/24 | | |
PEPPER, NCT02810704: Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement |
|
|
| Recruiting | 4 | 20000 | Canada, US | Enteric Coated Aspirin, Aspirin, Warfarin, Coumadin, Rivaroxaban, Xarelto | Dartmouth-Hitchcock Medical Center, Patient-Centered Outcomes Research Institute, University of Maryland, Baltimore, Brigham and Women's Hospital, Northwestern University, Medical University of South Carolina | Pulmonary Embolism, Venous Thrombosis | 07/25 | 07/25 | | |
ChiCTR2300074296: Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after thoracoscopic surgery for lung cancer: an open-label, multicenter, randomized, controlled trial |
|
|
| Not yet recruiting | 4 | 540 | | Oral rivaroxaban prolongs prophylactic anticoagulation ;none | Shanghai Pulmonary Hospital; Shanghai Pulmonary Hospital, Scientific research fund | Venous Thromboembolism | | | | |
| Recruiting | 4 | 6660 | Europe | Dalteparin Sodium, Tinzaparin Sodium, Enoxaparin Sodium, Rivaroxaban, Apixaban, Dabigatran Etexilate | Imperial College London | Venous Thromboembolism, Varicose Veins | 06/26 | 12/26 | | |
DANNOAC-VTE, NCT03129555: The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism |
|
|
| Recruiting | 4 | 5000 | Europe | Dabigatran Etexilate Oral Capsule, Rivaroxaban Oral Tablet, Edoxaban Oral Tablet, Apixaban Oral Tablet | Herlev and Gentofte Hospital, Danish Society of Cardiology | Deep Vein Thrombosis, Pulmonary Embolism | 03/27 | 03/29 | | |
ACTRN12609000762257: Assessment of microbleeding after prophylaxis with enoxaparin or rivaroxaban against venous thromboembolic disease following hip and knee surgery |
|
|
| Completed | 3/4 | 1060 | | | Launceston General Hospital, Launceston General Hospital | Prevention and treatment of venous thromboembolism (VTE); comprising deep vein thrombosis (DVT) and pulmonary embolism (PE) after hip and knee arthroplasty. | | | | |
